FY25 Ka Performance Kaisa Raha?
So, Blue Jet Healthcare ne FY25 mein sach mein achha kaam kiya hai. Unka consolidated revenue 23% badh kar ₹568 Crore ho gaya, aur net profit bhi 25% upar jaakar ₹96.8 Crore tak pahuncha. Quarter 4 (Q4 FY25) bhi zabardast raha, revenue 36% badh kar ₹170.8 Crore aur profit 39% badh kar ₹31.2 Crore ho gaya.
Kab Hai Call Aur Kaun Batayega?
Ye saari details aur future strategies par discussion ke liye, company 25 May, 2026 ko shaam 4:00 PM IST par ek earnings call organize kar rahi hai. Managing Director aur CFO khud aa kar sab explain karenge.
Investors Kya Dekhenge?
Blue Jet Healthcare main toh Active Pharmaceutical Ingredients (APIs), intermediates aur specialty chemicals banati hai. Ab investors ka focus hoga ki company FY26 mein growth kaise maintain karegi, margins kaise rahenge, aur kya koi naye products ya expansion plans hain. Competition kaafi tough hai market mein, jaise Suven Pharmaceuticals, Laurus Labs, Divi's Laboratories, aur Aarti Drugs bhi hain, toh is sabke beech company apna stand kaise banati hai, ye dekhna interesting hoga.